COMBINING A NOVEL PAN-RAF INHIBITOR WITH MEK INHIBITION IN PEDIATRIC, ADOLESCENT, AND YOUNG ADULT ACUTE MYELOID LEUKEMIA (AML)

Regents Of The University Of California, San Francisco, The

Investigators